|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 29 March 2006
doi: 10.1242/dev.02343
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Genetics, Stanford University Medical School, Stanford, CA
94062, USA.
2 Department of Biochemistry, Rappaport Faculty of Medicine, Technion-Israel
Institute of Technology, Haifa 31096, Israel.
* Author for correspondence (e-mail: jbaker{at}stanford.edu)
Accepted 27 February 2006
Convergent extension is the primary driving force elongating the anteroposterior body axis. In Xenopus, convergent extension occurs in the dorsal mesoderm and posterior neural ectoderm, and is mediated by similar molecular pathways within these tissues. In this paper, we show that activation of NF-AT, a transcription factor known to modulate multiple signaling events, inhibits convergent extension in the dorsal mesoderm and in the posterior neural ectoderm. This is seen in whole embryos, mesodermal explants and posterior neural explants, solidly implicating a role of NF-AT in convergent extension. In the whole embryo, inhibition of NF-AT reveals a more selective function, affecting only convergent extension in the neural ectoderm. This specific activity was further teased apart using a variety of temporal and spatial approaches. Targeted injections of dominant-negative XNF-ATc3, or dosing over time with the calcineurin inhibitor cyclosporin in neural tube explants or in whole embryos, shows that inhibition of NF-AT signaling blocks neural convergent extension. Consistent with a function in neural convergent extension, we show that XNF-ATc3 is expressed and transcriptionally active within the neural tube. This work identifies XNF-ATc3 as a regulator of neural convergent extension in Xenopus and adds to a short list of molecules involved in this process.
Key words: Convergent extension, NF-AT, Xenopus, Neural CE